|
1CZZ
STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 17-RESIDUE CD40 PEPTIDE
Deposited 1999-09-07
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
250–258(9 aa)
Fragment:TRAF2-BINDING REGION
Chain E
250–258(9 aa)
Fragment:TRAF2-BINDING REGION
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.6;293 K;PEG4K, MES, PH 5.6, VAPOR DIFFUSION, temperature 293K
|
Resolution 2.70 Å
R-free 0.267
|
|
1D00
STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
Deposited 1999-09-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain I
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;293 K;PEG4K, MES, Ph6.0, VAPOR DIFFUSION, temperature 20K
|
Resolution 2.00 Å
R-free 0.254
|
|
1D00
STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
Deposited 1999-09-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain K
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
Chain L
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
Chain M
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;293 K;PEG4K, MES, Ph6.0, VAPOR DIFFUSION, temperature 20K
|
Resolution 2.00 Å
R-free 0.254
|
|
1D00
STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
Deposited 1999-09-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain N
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
Chain O
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
Chain P
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;293 K;PEG4K, MES, Ph6.0, VAPOR DIFFUSION, temperature 20K
|
Resolution 2.00 Å
R-free 0.254
|
|
1D00
STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE
Deposited 1999-09-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain J
250–254(5 aa)
Fragment:ACETYLATED 5-RESIDUE PEPTIDE
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;293 K;PEG4K, MES, Ph6.0, VAPOR DIFFUSION, temperature 20K
|
Resolution 2.00 Å
R-free 0.254
|
|
1FLL
MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3
Deposited 2000-08-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain X
246–266(21 aa)
Fragment:CD40 (246-266) PEPTIDE
|
Mutation:N246K, C258S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;294 K;METHANOL, SODIUM CHLORIDE, TRIS BUFFER, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 3.50 Å
R-free 0.312
|
|
1FLL
MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3
Deposited 2000-08-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain Y
246–266(21 aa)
Fragment:CD40 (246-266) PEPTIDE
|
Mutation:N246K, C258S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;294 K;METHANOL, SODIUM CHLORIDE, TRIS BUFFER, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 3.50 Å
R-free 0.312
|
|
1FLL
MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3
Deposited 2000-08-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain Y
246–266(21 aa)
Fragment:CD40 (246-266) PEPTIDE
|
Mutation:N246K, C258S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;294 K;METHANOL, SODIUM CHLORIDE, TRIS BUFFER, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 3.50 Å
R-free 0.312
|
|
1LB6
TRAF6-CD40 Complex
Deposited 2002-04-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
230–238(9 aa)
Fragment:residues 230-238
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;PEG8000, Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.80 Å
R-free 0.258
|
|
5DMI
Structure of the extracellular domain of the CD40 in complex with CHI220 FAB
Deposited 2015-09-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
23–193(171 aa)
Fragment:Extracellular domain residues 23-193
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;80mM sodiym acetate, pH 4.6, 1.6 M ammonium sulfate, 20% (v/v) glycerol
|
Resolution 3.69 Å
R-free 0.207
|
|
5DMJ
Structure of the extracellular domain of the CD40 in complex with 3H56-5 DAB
Deposited 2015-09-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
23–193(171 aa)
|
Mutation:D153, D180
|
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;100mM Citric Acid, pH 3.5, 20% (w/v) PEG 4000, 200 mM potassium formate
|
Resolution 2.79 Å
R-free 0.258
|
|
5DMJ
Structure of the extracellular domain of the CD40 in complex with 3H56-5 DAB
Deposited 2015-09-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
23–193(171 aa)
|
Mutation:D153, D180
|
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;100mM Citric Acid, pH 3.5, 20% (w/v) PEG 4000, 200 mM potassium formate
|
Resolution 2.79 Å
R-free 0.258
|
|
5DMJ
Structure of the extracellular domain of the CD40 in complex with 3H56-5 DAB
Deposited 2015-09-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
23–193(171 aa)
|
Mutation:D153, D180
|
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;100mM Citric Acid, pH 3.5, 20% (w/v) PEG 4000, 200 mM potassium formate
|
Resolution 2.79 Å
R-free 0.258
|
|
5IHL
STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB
Deposited 2016-02-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
23–193(171 aa)
Fragment:Extra Cellular Domain (UNP residues 23-193)
|
Mutation:Protein produced with Asn 153 & Asn 180, but deglycosylated with PNGase F, which leaves Asp at those positions
|
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;80mM Tris-HCl, pH 8.5, 1.6M Ammonium dihydrogen phosphate, 20% (v/v) Glycerol
|
Resolution 3.30 Å
R-free 0.298
|
|
5IHL
STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB
Deposited 2016-02-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
23–193(171 aa)
Fragment:Extra Cellular Domain (UNP residues 23-193)
|
Mutation:Protein produced with Asn 153 & Asn 180, but deglycosylated with PNGase F, which leaves Asp at those positions
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;80mM Tris-HCl, pH 8.5, 1.6M Ammonium dihydrogen phosphate, 20% (v/v) Glycerol
|
Resolution 3.30 Å
R-free 0.298
|
|
5IHL
STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB
Deposited 2016-02-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
23–193(171 aa)
Fragment:Extra Cellular Domain (UNP residues 23-193)
|
Mutation:Protein produced with Asn 153 & Asn 180, but deglycosylated with PNGase F, which leaves Asp at those positions
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;80mM Tris-HCl, pH 8.5, 1.6M Ammonium dihydrogen phosphate, 20% (v/v) Glycerol
|
Resolution 3.30 Å
R-free 0.298
|
|
5IHL
STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB
Deposited 2016-02-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
23–193(171 aa)
Fragment:Extra Cellular Domain (UNP residues 23-193)
|
Mutation:Protein produced with Asn 153 & Asn 180, but deglycosylated with PNGase F, which leaves Asp at those positions
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 3.5;293 K;80mM Tris-HCl, pH 8.5, 1.6M Ammonium dihydrogen phosphate, 20% (v/v) Glycerol
|
Resolution 3.30 Å
R-free 0.298
|
|
6FAX
Complex of Human CD40 Ectodomain with Lob 7.4 Fab
Deposited 2017-12-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain R
21–193(173 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;NA
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;NA
|
Resolution 2.99 Å
R-free 0.231
|
|
6PE8
Crystal structure of CD40/ABBV-323 FAB complex
Deposited 2019-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain U
21–193(173 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;2M ammonium sulfate, 0.1M phosphate-citrate pH 4.2
|
Resolution 2.84 Å
R-free 0.265
|
|
6PE8
Crystal structure of CD40/ABBV-323 FAB complex
Deposited 2019-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain T
21–193(173 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;2M ammonium sulfate, 0.1M phosphate-citrate pH 4.2
|
Resolution 2.84 Å
R-free 0.265
|
|
6PE9
Crystal Structure of CD40 complexed to FAB516
Deposited 2019-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain I
21–193(173 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;1.6M Ammonium Sulfate
2% w/v PEG1000, 100 mM HEPES Sodium Salt pH 7.5
|
Resolution 3.13 Å
R-free 0.255
|
|
6PE9
Crystal Structure of CD40 complexed to FAB516
Deposited 2019-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain G
21–193(173 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;1.6M Ammonium Sulfate
2% w/v PEG1000, 100 mM HEPES Sodium Salt pH 7.5
|
Resolution 3.13 Å
R-free 0.255
|
|
6PE9
Crystal Structure of CD40 complexed to FAB516
Deposited 2019-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain U
21–193(173 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;1.6M Ammonium Sulfate
2% w/v PEG1000, 100 mM HEPES Sodium Salt pH 7.5
|
Resolution 3.13 Å
R-free 0.255
|
|
6PE9
Crystal Structure of CD40 complexed to FAB516
Deposited 2019-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain V
21–193(173 aa)
|
Not recorded
|
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;1.6M Ammonium Sulfate
2% w/v PEG1000, 100 mM HEPES Sodium Salt pH 7.5
|
Resolution 3.13 Å
R-free 0.255
|
|
6PE9
Crystal Structure of CD40 complexed to FAB516
Deposited 2019-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain J
21–193(173 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;296.15 K;1.6M Ammonium Sulfate
2% w/v PEG1000, 100 mM HEPES Sodium Salt pH 7.5
|
Resolution 3.13 Å
R-free 0.255
|
|
7P3I
Crystal structure of human CD40/TNFRSF5 in complex with the anti-CD40 DARPin protein
Deposited 2021-07-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
21–193(173 aa)
Fragment:>FRAGMENT<
|
Not recorded
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;29.9999 %w/v PEG 4K, 0.24 M LiSO4, 0.0999 M TRIS, 0.35 M NaBr
|
Resolution 2.29 Å
R-free 0.253
|
|
7P3I
Crystal structure of human CD40/TNFRSF5 in complex with the anti-CD40 DARPin protein
Deposited 2021-07-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
21–193(173 aa)
Fragment:>FRAGMENT<
|
Not recorded
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;29.9999 %w/v PEG 4K, 0.24 M LiSO4, 0.0999 M TRIS, 0.35 M NaBr
|
Resolution 2.29 Å
R-free 0.253
|
|
8YX1
CD40 in complex with Bleselumab Fab
Deposited 2024-04-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain R
21–193(173 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M Ammonium chloride
20% w/v Polyethylene glycol 3,350
|
Resolution 2.70 Å
R-free 0.265
|
|
8YX1
CD40 in complex with Bleselumab Fab
Deposited 2024-04-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
21–193(173 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M Ammonium chloride
20% w/v Polyethylene glycol 3,350
|
Resolution 2.70 Å
R-free 0.265
|
|
8YX9
CD40 in complex with Dacetuzumab Fab
Deposited 2024-04-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
21–193(173 aa)
|
Not recorded
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M Ammonium citrate tribasic pH 7.0
20% w/v Polyethylene glycol 3,350
|
Resolution 2.80 Å
R-free 0.262
|
|
8YX9
CD40 in complex with Dacetuzumab Fab
Deposited 2024-04-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain J
21–193(173 aa)
|
Not recorded
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M Ammonium citrate tribasic pH 7.0
20% w/v Polyethylene glycol 3,350
|
Resolution 2.80 Å
R-free 0.262
|
|
8YX9
CD40 in complex with Dacetuzumab Fab
Deposited 2024-04-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
21–193(173 aa)
|
Not recorded
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M Ammonium citrate tribasic pH 7.0
20% w/v Polyethylene glycol 3,350
|
Resolution 2.80 Å
R-free 0.262
|
|
8YX9
CD40 in complex with Dacetuzumab Fab
Deposited 2024-04-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain K
21–193(173 aa)
|
Not recorded
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M Ammonium citrate tribasic pH 7.0
20% w/v Polyethylene glycol 3,350
|
Resolution 2.80 Å
R-free 0.262
|